ScholarIQanswers from OpenAlex

DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations

PaperCitations, authors & open-access status

DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations is a paper indexed in ScholarIQ from OpenAlex.

How many citations does DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations have?

ScholarIQcitation count

DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations has 136 citations in the OpenAlex counts ScholarIQ stores.

When was DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations published?

ScholarIQyear

DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations has 2016 year in the ScholarIQ index.

What is the open-access status of DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations?

ScholarIQoa status

DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations has gold oa status in the ScholarIQ index.

What is the DOI of DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations?

ScholarIQdoi

The DOI for DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations is on the source record.

What is the PMID of DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations?

ScholarIQpmid

The PMID for DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations is on the source record.

What is the OpenAlex record for DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations?

ScholarIQopenalex

The OpenAlex for DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial